(Q48459667)

11 February 2018

title

Number of primary melanomas is an independent predictor of survival in patients with metastatic melanoma. (English)

1 reference

11 February 2018

1 reference

1

1 reference

11 February 2018

Richard F. Kefford

3

1 reference

11 February 2018

Richard Scolyer

4

1 reference

11 February 2018

Georgina V. Long

7

1 reference

11 February 2018

John F Thompson

5

object named as

John F Thompson

1 reference

11 February 2018

Michael B Atkins

6

object named as

Michael B Atkins

1 reference

11 February 2018

author name string

Philip T Brown

2

1 reference

11 February 2018

language of work or name

English

0 references

publication date

26 June 2012

1 reference

11 February 2018

published in

Cancer

1 reference

11 February 2018

volume

118

1 reference

11 February 2018

issue

18

1 reference

11 February 2018

page(s)

4519-4529

1 reference

11 February 2018

Final version of the American Joint Committee on Cancer staging system for cutaneous melanoma

cites work

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27693

Prognostic factors analysis of 17,600 melanoma patients: validation of the American Joint Committee on Cancer melanoma staging system

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27693

Final version of 2009 AJCC melanoma staging and classification

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27693

The prognostic significance of ulceration of cutaneous melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27693

Toxicity and response criteria of the Eastern Cooperative Oncology Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27693

Prognostic factors for survival of patients treated systemically for disseminated melanoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27693

Multiple primary melanoma: risk factors and prognostic implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27693

Enhanced survival in patients with multiple primary melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27693

Evaluation of the clonal origin of multiple primary melanomas using molecular profiling

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27693

LDH correlation with survival in advanced melanoma from two large, randomised trials (Oblimersen GM301 and EORTC 18951).

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27693

Prognostic factors in metastatic melanoma: a pooled analysis of Eastern Cooperative Oncology Group trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27693

Prognostic and clinicopathologic associations of oncogenic BRAF in metastatic melanoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27693

A comparison of prognostic factors and surgical results in 1,786 patients with localized (stage I) melanoma treated in Alabama, USA, and New South Wales, Australia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27693

7 January 2021

The prognostic importance of tumor mitotic rate confirmed in 1317 patients with primary cutaneous melanoma and long follow-up

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27693

7 January 2021

Tumor mitotic rate is a more powerful prognostic indicator than ulceration in patients with primary cutaneous melanoma: an analysis of 3661 patients from a single center

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27693

7 January 2021

Overall and progression-free survival in metastatic melanoma: analysis of a single-institution database

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27693

7 January 2021

Identifiers

DOI

10.1002/CNCR.27693

1 reference

11 February 2018

PubMed ID

22736239

1 reference

11 February 2018